发明名称 |
METHOD, PHARMACEUTICAL COMPOSITION AND KIT FOR APPLYING METFORMIN AND SODIUM BUTYRATE IN KRAS MUTATION CANCER TREATMENT |
摘要 |
A method for using metformin and sodium butyrate in combination to treat a cancer patient with K-ras mutation is disclosed. When administering the pharmaceutical composition to a cancer patient, Metformin and sodium butyrate offer cooperatively therapeutic efficacy. The present invention also discloses a pharmaceutical composition and a pharmaceutical kit containing both aforementioned. The application of the method, the pharmaceutical composition and the pharmaceutical kit of the present invention are advantageous for improving the treatment effect to cancer patients with K-ras mutation. |
申请公布号 |
US2014343144(A1) |
申请公布日期 |
2014.11.20 |
申请号 |
US201414157873 |
申请日期 |
2014.01.17 |
申请人 |
Uropro Biotech Co., Ltd |
发明人 |
CHI Kwan-Hwa;WANG Yu-Shan;CHANG Chao-Chun |
分类号 |
A61K31/19;A61K31/155 |
主分类号 |
A61K31/19 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for using a metformin and a sodium butyrate for treating a cancer patient with K-ras mutation, wherein when the pharmaceutical composition is administered to the cancer patient, the metformin and the sodium butyrate offer cooperatively therapeutic efficacy. |
地址 |
Taipei City TW |